Zhejiang Starry Pharmaceutical Co., Ltd.

　Established in 1997, Zhejiang Starry Pharmaceutical Co., Ltd. is a high-tech enterprise specialized in research and development, production and sales of X-CT nonionic iodine contrast agent series and quinolone series bulk drugs and intermediates. It is currently the production base of diagnostic bulk drugs in China. The company was listed on the Shanghai Stock Exchange on March 9, 2016 (Stock Code: 603520).

Over the past 20 years, the company has maintained a good and stable development momentum and has become the leading enterprise of X-CT nonionic contrast agent bulk drugs in China. The products that have the industrialization capability include iohexol bulk drug, iopamidol bulk drug, iodophor bulk drug, iopromide bulk drug, iodixanol bulk drug, etc. Among them, the production capacity and output of iohexol bulk drug rank first in China. With stable quality, the company's products have been certified by many developed countries. At present, there are 4 manufacturers of iohexol bulk drug worldwide that have obtained EU CEP certificate, among whom Starry is the only one in China. In addition, Starry is among the 4 manufacturers of iohexol bulk drug worldwide that have obtained Japan’s access certificate.

Zhejiang Starry Pharmaceutical Co., Ltd.

Free sales call 800 9576 788

Tel ：0576-87718628

Fax ：0576-87718668

Zip ：317306

Mail ：sales@starrypharma.com

Web： www.starrypharm.com

Add：No.9, Fengxi West Road, Xianju modern industrial cluster, Zhejiang Province

Shanghai Office (International Trade)

Tel：021-37916067

Fax：021-37916082

Zip：201506

Mail：sales@starrypharma.com

Web：www.starrypharm.com

Add：No. 500, Maoye Road, Jinshan District, Shanghai